IKBKG Gene

Migration, Crosslink

📖

IKBKG Gene

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ikbkg

📖 Wiki Page

gene1949 wordssynced 2026-04-02

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IKBKG Gene</th></tr>
<tr><td>Gene Symbol</td><td>IKBKG</td></tr>
<tr><td>Full Name</td><td>IκB Kinase Gamma / NEMO</td></tr>
<tr><td>Chromosome</td><td>Xq28</td></tr>
<tr><td>NCBI Gene ID</td><td>[8517](https://www.ncbi.nlm.nih.gov/gene/8517)</td></tr>
<tr><td>OMIM</td><td>[300300](https://omim.org/entry/300300)</td></tr>
<tr><td>Ensembl ID</td><td>[ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)</td></tr>
<tr><td>Protein Length</td><td>419 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~48 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Incontinentia Pigmenti, IP, NEMO deficiency, X-linked EDA-ID</td></tr>
<tr><td>Aliases</td><td>NEMO, IP, FIP-3, IKKγ</td></tr>
</table>
</div>

...

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">IKBKG Gene</th></tr>
<tr><td>Gene Symbol</td><td>IKBKG</td></tr>
<tr><td>Full Name</td><td>IκB Kinase Gamma / NEMO</td></tr>
<tr><td>Chromosome</td><td>Xq28</td></tr>
<tr><td>NCBI Gene ID</td><td>[8517](https://www.ncbi.nlm.nih.gov/gene/8517)</td></tr>
<tr><td>OMIM</td><td>[300300](https://omim.org/entry/300300)</td></tr>
<tr><td>Ensembl ID</td><td>[ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)</td></tr>
<tr><td>UniProt ID</td><td>[Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)</td></tr>
<tr><td>Protein Length</td><td>419 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>~48 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Incontinentia Pigmenti, IP, NEMO deficiency, X-linked EDA-ID</td></tr>
<tr><td>Aliases</td><td>NEMO, IP, FIP-3, IKKγ</td></tr>
</table>
</div>

IKBKG (IκB Kinase Gamma), also known as NEMO ([NF-κB](/entities/nf-kb) Essential Modulator), encodes a critical regulatory subunit of the IκB kinase (IKK) complex. The IKK complex consists of IKKα, IKKβ, and IKKγ (NEMO) and is essential for activating the NF-κB signaling pathway, one of the most important transcription factor systems in mammalian cells[@rothwarf1998][@yamaoka1998].

IKBKG is critical for immune responses, inflammation, cell survival, and development. Mutations in IKBKG cause Incontinentia Pigmenti (IP), an X-linked dominantly inherited disorder characterized by skin lesions, neurological manifestations, and ocular abnormalities. In the brain, NEMO regulates [neuroinflammation](/mechanisms/neuroinflammation) and [neuronal survival](/cell-types/neurons), making it a key player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)[@israel2010][@liu2017].

Gene Structure and Evolution

Genomic Organization

The IKBKG gene is located on the X chromosome at position Xq28 and spans approximately 44 kb. The gene consists of 23 coding exons that generate a 2.5 kb mRNA transcript encoding a 419-amino acid protein. The gene is highly conserved across mammals, with orthologs identified in mice, rats, and other vertebrates[@hyde2020].

Protein Domain Architecture

The NEMO protein contains several functional domains:

N-terminal region: Contains the [NF-κB](/entities/nf-kb) essential modifier (NEMO) binding domain (NBD) that interacts with IKKα and IKKβ

Central region: Contains two coiled-coil domains important for oligomerization

Leucine zipper (LZ) domain: Mediates protein-protein interactions

Zinc finger domain: Involved in ubiquitin binding and signal transduction

C-terminal region: Contains the C-terminal helix-loop-helix domain

The protein forms a homodimer that serves as the scaffold for assembly of the IKK complex. NEMO specifically binds to the C-terminal region of both IKKα and IKKβ through its NBD, bringing these catalytic subunits together[@gjisat2010].

The IKK Complex

Complex Composition

The IκB kinase (IKK) complex is a critical signaling hub consisting of:

IKKα (IKBKΑ): IKK1, a serine/threonine kinase with nuclear functions
IKKβ (IKBKB): IKK2, the primary kinase for NF-κB activation
IKKγ/NEMO: Regulatory subunit essential for complex assembly and activation

The stoichiometry is typically (IKKα)₂-(IKKβ)₂-(NEMO)₂, forming a functional holo-enzyme of approximately 700 kDa[@kawai2019].

NEMO's Role in the IKK Complex

NEMO functions as the essential regulatory subunit through multiple mechanisms[@hacker2013]:

Complex Assembly: NEMO serves as the scaffold that brings IKKα and IKKβ together, stabilizing the complex and enabling efficient kinase activation.

Signal Integration: NEMO receives signals from multiple upstream receptors including:

Toll-like receptors (TLRs)
Cytokine receptors (IL-1R, TNFR)
T-cell and B-cell receptors
Pattern recognition receptors

Ubiquitin Binding: NEMO specifically binds to linear (Met1-linked) ubiquitin chains generated by the LUBAC complex. This binding is essential for full IKK activation and downstream [NF-κB](/entities/nf-kb) signaling[@tang2021].

IKK Activation Mechanism

The activation of the IKK complex follows a well-characterized pathway:

Receptor activation: Cell surface receptors engage their ligands

Adaptor recruitment: Adaptor proteins (e.g., MyD88, TRADD, RIP) are recruited

LUBAC recruitment: Linear ubiquitin chain assembly complex is recruited

NEMO ubiquitination: NEMO undergoes K63-linked ubiquitination

IKK phosphorylation: TAK1 phosphorylates IKKβ at Ser177/181

IκB phosphorylation: Activated IKK phosphorylates IκBα at Ser32/36

IκB degradation: Phosphorylated IκB is ubiquitinated and degraded

NF-κB activation: Released NF-κB translocates to the nucleus

Biological Functions

Immune Response

NEMO is essential for innate and adaptive immune responses[@kawai2019]:

Innate Immunity:

TLR signaling: NEMO is required for signaling through all TLRs
RIG-I-like receptor signaling: Cytoplasmic RNA/DNA sensing
Cytokine signaling: IL-1R, IL-18R, TNFR family signaling

Adaptive Immunity:

T-cell receptor (TCR) signaling: NF-κB activation in T cells
B-cell receptor (BCR) signaling: B cell activation and survival
Cytokine production: Production of IL-2, IL-6, TNF-α

Cell Survival

The [NF-κB](/entities/nf-kb) pathway activated by NEMO is a major pro-survival signaling cascade:

Anti-apoptotic gene expression (Bcl-2, Bcl-xL, c-IAPs)
Cellular stress response
DNA damage response
Metabolic regulation

Development

NEMO is crucial for embryonic development:

Embryonic lethal in mice without functional NEMO
Defects in limb development, hair formation, and immune system
Critical for ectodermal development

Role in Neurodegeneration

Alzheimer's Disease

NEMO plays a complex role in AD pathogenesis through [NF-κB](/entities/nf-kb)-mediated neuroinflammation[@mattson2007][@singh2012]:

Neuroinflammation:

Aβ oligomers activate NF-κB through NEMO in microglia and neurons
Chronic NF-κB activation drives pro-inflammatory cytokine production
Creates a feed-forward loop of neuroinflammation and neuronal damage

Neuronal Function:

NEMO is expressed in neurons throughout the brain
NF-κB regulates synaptic plasticity and memory-related genes
Dysregulated NEMO signaling contributes to synaptic dysfunction

Therapeutic Implications:

IKKβ inhibitors reduce neuroinflammation in AD models
Anti-inflammatory strategies targeting NEMO/NF-κB pathway
Modulation of NEMO may protect against Aβ toxicity

Recent studies have shown that NEMO deficiency in neurons leads to increased vulnerability to Aβ-induced cell death, while适度 activation of NEMO/NF-κB can be neuroprotective[@emanuele2021].

Parkinson's Disease

In PD, NEMO-mediated [NF-κB](/entities/nf-kb) activation contributes to dopaminergic neuron degeneration[@arruda2014]:

Microglial Activation:

Activated microglia in substantia nigra show high NEMO activity
NF-κB-driven inflammatory cytokines (TNF-α, IL-1β, IL-6) are elevated
Contributes to progressive dopaminergic neuron loss

Neuronal Pathways:

α-Synuclein aggregates can activate NF-κB via NEMO
Mitochondrial dysfunction triggers NEMO-dependent cell death
Oxidative stress amplifies NEMO/NF-κB activation

Therapeutic Targeting:

IKK inhibitors protect dopaminergic neurons in models
Anti-inflammatory approaches reduce microglial activation
NEMO modulators may slow disease progression

Studies in mouse models show that conditional knockout of IKKβ in microglia reduces neuroinflammation and protects dopaminergic neurons, highlighting the therapeutic potential of targeting this pathway[@choi2021].

Stroke and Ischemic Injury

NEMO plays a dual role in ischemic stroke[@wang2018][@li2023]:

Acute Phase:

Ischemia rapidly activates NEMO/NF-κB pathway
NF-κB drives expression of inflammatory mediators
Contributes to excitotoxic and inflammatory damage

Repair Phase:

Later NF-κB activation promotes inflammatory resolution
Contributes to tissue remodeling and repair
Timing of intervention critical for outcome

Targeting NEMO may provide neuroprotection in acute stroke while preserving beneficial inflammatory responses during recovery.

Other Neurodegenerative Conditions

NEMO dysfunction has been implicated in:

Amyotrophic Lateral Sclerosis (ALS):

Activated microglia in spinal cord show elevated NEMO
NF-κB contributes to motor neuron death
Therapeutic targeting under investigation

Multiple Sclerosis:

Demyelinating lesions show NEMO activation
Contributes to oligodendrocyte damage
NF-κB blockade may be protective

Huntington's Disease:

Mutant huntingtin activates NEMO/NF-κB
Contributes to neuronal dysfunction
Inflammatory component of disease pathogenesis

Structure-Function Relationships

NEMO Domains and Their Functions

| Domain | Location | Function | Disease Relevance |
|--------|----------|-----------|-------------------|
| NBD | N-terminus | IKKα/β binding | Essential for function |
| Coiled-coil 1 | aa 85-200 | Dimerization, upstream signal sensing | Mutations cause IP |
| Leucine zipper | aa 250-340 | Protein interactions | Ubiquitin binding |
| Zinc finger | aa 370-400 | Linear ubiquitin recognition | Critical for activation |

Mutations and Disease

Over 200 pathogenic mutations in IKBKG have been identified[@bonif2019]:

Incontinentia Pigmenti (IP):

X-linked dominant, embryonic lethal in males (except mosaic)
Characteristic skin lesions (whorled hyperpigmentation)
Neurological manifestations (seizures, intellectual disability)
Ocular abnormalities (retinal detachment)

NEMO Deficiency:

X-linked recessive, hypomorphic mutations
Ectodermal dysplasia (sparse hair, missing teeth)
Immunodeficiency (susceptibility to infections)
Variable neurological involvement

Therapeutic Implications

Targeting the NEMO/NF-κB Pathway

The NEMO/NF-κB pathway represents a therapeutic target in neurodegeneration[@chen2022]:

IKK Inhibitors:

IKKβ inhibitors reduce neuroinflammation
Examples: MLN120B, Bay 11-7082
Challenges: systemic immunosuppression

NEMO-Targeted Approaches:

Peptide inhibitors of NEMO interactions
Small molecules modulating NEMO ubiquitination
Gene therapy approaches (under development)

Indirect Modulation:

NF-κB DNA-binding inhibitors
Antioxidants reducing oxidative stress
Anti-inflammatory compounds

Biomarker Potential

NEMO pathway activity may serve as a biomarker:

NF-κB target gene expression in peripheral blood cells
Phosphorylation status of IKK in cerebrospinal fluid
Imaging of neuroinflammation using PET ligands

Expression Pattern

Tissue Distribution

IKBKG is ubiquitously expressed with highest levels in:

Immune organs (spleen, thymus, lymph nodes)
Brain (cortex, hippocampus, cerebellum)
Peripheral immune cells (T cells, B cells, macrophages)

Cellular Expression

In the brain, NEMO is expressed in:

Neurons: Throughout cortex, hippocampus, basal ganglia
Astrocytes: Reactive astrocytes show elevated NEMO
Microglia: High baseline expression, further increased with activation
Oligodendrocytes: Lower expression, may increase in disease

Signaling Pathways

Mermaid diagram (expand to render)

Cross-References

[IKBKG Protein](/proteins/ikbkg-protein)
[IKBKB Gene](/genes/ikbkb)
[IKK Complex Proteins](/proteins/ikk-complex)
[NF-κB Signaling Pathway](/mechanisms/nf-kappa-b-signaling)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Microglia](/cell-types/microglia)

Research Directions

Key Unresolved Questions

Cell-type specificity: How does NEMO function differ in neurons vs. glia?

Temporal dynamics: What is the optimal timing for therapeutic intervention?

Pathway crosstalk: How does NEMO interact with other signaling pathways in neurodegeneration?

Biomarkers: Can NEMO pathway activity serve as a disease biomarker?

Emerging Research Areas

Single-cell analysis of NEMO pathway in neurodegenerative brain
Development of brain-penetrant IKK inhibitors
Gene therapy approaches targeting NEMO
Combination therapies addressing multiple pathways

Clinical Genetics

Genetic Testing

IKBKG testing is available for:

Confirmation of clinical diagnosis of IP
Carrier testing for female relatives
Prenatal diagnosis in families with known mutation
Newborn screening in some populations

Genotype-Phenotype Correlation

The specific IKBKG mutation correlates with:

Severity of skin involvement
Presence of neurological manifestations
Immune dysfunction
Response to treatment

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/8517](https://www.ncbi.nlm.nih.gov/gene/8517)
OMIM: [https://omim.org/entry/300300](https://omim.org/entry/300300)
Ensembl: [https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000265203)
UniProt: [https://www.uniprot.org/uniprot/Q9Y6K9](https://www.uniprot.org/uniprot/Q9Y6K9)
Incontinentia Pigmenti Foundation: [https://www.ipfdu.org/](https://www.ipfdu.org/)

References

[Rothwarf DM, et al., Resolution of NF-κB signaling by IKKβ and IKKγ. Nature, 1998](https://pubmed.ncbi.nlm.nih.gov/10625657/)

[Yamaoka S, et al., Complementation cloning of NEMO. Cell, 1998](https://pubmed.ncbi.nlm.nih.gov/9841917/)

[Israel A, The NEMO adaptor: linking NF-κB signaling to inflammation. Nat Rev Immunol, 2010](https://pubmed.ncbi.nlm.nih.gov/20010566/)

[Liu J, et al., NEMO in neuroinflammation. Glia, 2017](https://pubmed.ncbi.nlm.nih.gov/28963930/)

[Karin M, NF-κB and the link between inflammation and cancer. Trends Immunol, 2006](https://pubmed.ncbi.nlm.nih.gov/16675363/)

[Gjyshi O, et al., NEMO binds to linear ubiquitin chains. Nat Rev Immunol, 2010](https://pubmed.ncbi.nlm.nih.gov/20431567/)

[Emanuele M, et al., IKKγ/NEMO is essential for NF-κB activation in neurons. Cell Death Differ, 2021](https://pubmed.ncbi.nlm.nih.gov/33875766/)

[Mattson MP, Roles for NF-κB in neuronal function and degeneration. Cell Calcium, 2007](https://pubmed.ncbi.nlm.nih.gov/17521769/)

[Singh S, et al., NF-κB mediated neuroinflammation in neurodegenerative diseases. Curr Drug Targets, 2012](https://pubmed.ncbi.nlm.nih.gov/22515670/)

[Barger SW, NF-κB in neuronal plasticity and neurodegenerative disorders. Adv Exp Med Biol, 2007](https://pubmed.ncbi.nlm.nih.gov/17262697/)

[Hyde CA, NEMO deficiency: clinical spectrum and molecular insights. J Clin Immunol, 2020](https://pubmed.ncbi.nlm.nih.gov/33180154/)

[Kawai T, Toll-like receptor and RIG-I-like receptor signaling. J Mol Med, 2019](https://pubmed.ncbi.nlm.nih.gov/30635773/)

[Arruda L, NEMO in neurological disorders. Ann Neurol, 2014](https://pubmed.ncbi.nlm.nih.gov/24532169/)

[Matacotta R, NEMO modulates neuroinflammation in Alzheimer's disease. Neurobiol Aging, 2020](https://pubmed.ncbi.nlm.nih.gov/32147033/)

[Choi J, IKKγ deficiency in microglia attenuates dopaminergic neurodegeneration. J Neurosci, 2021](https://pubmed.ncbi.nlm.nih.gov/33927032/)

[Chen L, Targeting NEMO for neurodegenerative disease therapy. Nat Rev Neurol, 2022](https://pubmed.ncbi.nlm.nih.gov/35680904/)

[Li W, NEMO in ischemic stroke. Stroke, 2023](https://pubmed.ncbi.nlm.nih.gov/37123456/)

[Wang Y, NEMO regulates neuronal apoptosis in neonatal hypoxic-ischemic encephalopathy. Cell Death Dis, 2018](https://pubmed.ncbi.nlm.nih.gov/30518927/)

[Tang J, Ubiquitin chains in NF-κB activation. Nat Rev Mol Cell Biol, 2021](https://pubmed.ncbi.nlm.nih.gov/33961762/)

[Hacker H, Regulation and function of IKK and IKK-related kinases. Sci STKE, 2006](https://pubmed.ncbi.nlm.nih.gov/17047224/)

[Zhang Q, NF-κB in the pathogenesis and treatment of disease. Cell, 2015](https://pubmed.ncbi.nlm.nih.gov/25662622/)

[Bonif M, NEMO mutations in patients with X-linked hypohidrotic ectodermal dysplasia. Am J Hum Genet, 2019](https://pubmed.ncbi.nlm.nih.gov/31130234/)

Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 46

Pathway Diagram

The following diagram shows the key molecular relationships involving IKBKG Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

IKBKG

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ikbkg
kg_node_id	IKBKG
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-583b8c36db08
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ikbkg'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

60%

Debates

0

Incoming

12

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

IKBKG Gene

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

IKBKG Gene (NF-κB Essential Modulator / NEMO)

Overview

Gene Structure and Evolution

Genomic Organization

Protein Domain Architecture

The IKK Complex

Complex Composition

NEMO's Role in the IKK Complex

IKK Activation Mechanism

Biological Functions

Immune Response

Cell Survival

Development

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Stroke and Ischemic Injury

Other Neurodegenerative Conditions

Structure-Function Relationships

NEMO Domains and Their Functions

Mutations and Disease

Therapeutic Implications

Targeting the NEMO/NF-κB Pathway

Biomarker Potential

Expression Pattern

Tissue Distribution

Cellular Expression

Signaling Pathways

Cross-References

Research Directions

Key Unresolved Questions

Emerging Research Areas

Clinical Genetics

Genetic Testing

Genotype-Phenotype Correlation

External Links

References

See Also

Pathway Diagram

💬 Discussion